SALIX PHARMACEUTICALS LTD Deferred Tax Assets, Net of Valuation Allowance, Noncurrent
SALIX PHARMACEUTICALS LTD had Deferred Tax Assets, Net of Valuation Allowance, Noncurrent of $2.59 million as of 2012-03-31, per its 10-Q filed 2012-05-08.
Discontinued › Notes › Income Taxes
us-gaap:DeferredTaxAssetsNetNoncurrent · last filed 2012-11-08
- 2012-03-31: Deferred Tax Assets, Net of Valuation Allowance, Noncurrent $2.59M.
- 2011-12-31: Deferred Tax Assets, Net of Valuation Allowance, Noncurrent $2.59M.
| Period end | Deferred Tax Assets, Net of Valuation Allowance, Noncurrent |
|---|---|
| 2012-03-31 | $2.59M 10-Q · filed 2012-05-08 |
| 2011-12-31 | $2.59M 10-Q · filed 2012-11-08 |